ArticleFrontiers in medicine2026
Stereopsis impairment and its association with fovea-disc angle in congenital superior oblique palsy patients with compensatory head posture: a cross-sectional study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To characterize stereopsis impairment in patients with congenital superior oblique palsy (CSOP) with compensatory head posture (CHP) and to explore the fovea-disc angle (FDA) as a potential imaging parameter for assessing binocular visual dysfunction. Methods: This cross-sectional study enrolled 20 CSOP patients with CHP and 20 age- and sex-matched controls between November 2024 and March 2026. Stereopsis was assessed using the Titmus Stereotest, Randot Stereotest (near), and Distance Randot Stereotest under both the CHP and the primary position. Stereopsis was compared between CSOP patients and controls, and between the CHP and the primary position within the CSOP group. Stereopsis was categorized as normal (≤100 arcsec) or impaired (>100 arcsec), and the proportions of CSOP patients with impaired distance and near stereopsis under the CHP were compared. FDA was measured using fundus photography and an imaging analysis software in patients with CSOP. Correlation analyses were performed to evaluate the associations between log-transformed stereopsis and clinical parameters. Results: CSOP patients with CHP showed significantly worse stereopsis than controls (Titmus: Conclusion: CSOP patients with CHP exhibit impairment in both distance and near stereopsis, with distance stereopsis being more severely affected. Binocular FDA is negatively correlated with stereopsis and may serve as a promising imaging parameter for assessing binocular visual dysfunction in CSOP with CHP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.